Amit Maity
Overview
Explore the profile of Amit Maity including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
105
Citations
5153
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Howell J, Mark B, Wada D, Bowling M, Wei M, Lloyd S, et al.
Cancer Med
. 2025 Mar;
14(5):e70577.
PMID: 40052836
Background: We investigated mental health diagnoses (MHDs) in mycosis fungoides (MF) patients compared to the general population, evaluated risk factors, and studied survival outcomes in a large population database. Methods:...
2.
Mathew D, Ohri N, Ngiow S, Halmos B, Wumesh K, Garg M, et al.
medRxiv
. 2025 Feb;
PMID: 39974012
Non-small cell lung cancer (NSCLC) is the leading cause of cancer mortality worldwide. For patients who develop progressive disease after treatment with chemotherapy and immunotherapy, treatment options are limited. Here,...
3.
Verginadis I, Velalopoulou A, Kim M, Kim K, Paraskevaidis I, Bell B, et al.
Radiother Oncol
. 2025 Jan;
205:110744.
PMID: 39880309
Background And Purpose: The normal tissue sparing afforded by FLASH radiotherapy is being intensely investigated for potential clinical translation. Here, we studied the effects of FLASH proton radiotherapy (F-PRT) in...
4.
Verginadis I, Citrin D, Ky B, Feigenberg S, Georgakilas A, Hill-Kayser C, et al.
Lancet
. 2025 Jan;
405(10475):338-352.
PMID: 39827884
For over a century, radiotherapy has revolutionised cancer treatment. Technological advancements aim to deliver high doses to tumours with increased precision while minimising off-target effects to organs at risk. Despite...
5.
Kostopoulos N, Costabile F, Krimitza E, Beghi S, Goia D, Perales-Linares R, et al.
Blood Adv
. 2024 Aug;
8(24):6308-6320.
PMID: 39213422
Chimeric antigen receptor (CAR) T-cell therapy targeting CD19 (CART-19) represents a significant advance in the treatment of patients with relapsed or refractory CD19+ B-cell lymphomas. However, a significant portion of...
6.
Xia W, Goff M, Schiavone C, Singh N, Huang J, Need E, et al.
bioRxiv
. 2024 Aug;
PMID: 39211061
Tumor hypoxia leads to radioresistance and markedly worse clinical outcomes for pediatric malignant rhabdoid tumors (MRT). Our transcriptomics and bioenergetic profiling data reveal that mitochondrial oxidative phosphorylation (OXPHOS) is a...
7.
Verginadis I, Velalopoulou A, Kim M, Kim K, Paraskevaidis I, Bell B, et al.
bioRxiv
. 2024 Jul;
PMID: 39026805
Background And Purpose: The normal tissue sparing afforded by FLASH radiotherapy (RT) is being intensely investigated for potential clinical translation. Here, we studied the effects of FLASH proton RT (F-PRT)...
8.
Baron J, Wright C, Dreyfuss A, Chong E, Svoboda J, LaRiviere M, et al.
Pract Radiat Oncol
. 2024 Jul;
14(5):e362-e372.
PMID: 38971218
Purpose: To assess whether a radiation therapy (RT) dose affects response in bulky tumors in relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL). Methods And Materials: Data from patients with r/r...
9.
Perales-Linares R, Leli N, Mohei H, Beghi S, Rivera O, Kostopoulos N, et al.
Cancer Res
. 2023 Aug;
83(21):3562-3576.
PMID: 37578274
Significance: Parkin prevents immune evasion by regulating tumor antigen processing and presentation through the PTEN/Akt network, which has important implications for immunotherapy treatments in patients with Parkin-deficient tumors.
10.
Zhu Y, Alexander D, Miao T, Maity A, Plastaras J, Paydar I, et al.
Proc SPIE Int Soc Opt Eng
. 2023 May;
12359.
PMID: 37124379
Cherenkov images can be used for the quality assurance of dose homogeneity in total skin electron therapy (TSET). For the dose mapping purpose, this study reconstructed the patient model from...